drugset / Trial / NCT00371007
MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)
RandomizedParallel-groupDouble-blindTreatment
Summary
A clinical study to determine the safety and efficacy of MK-0431 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy
Timeline
- Start
- 2004-06-01
- Primary completion
- 2005-04-25
- Completion
- 2005-04-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sitagliptin | Small molecule | — | — |